Algorithm Sciences, a Laidlaw Venture Partners Portfolio Company, Announces Board Appointments
04 oct. 2021 09h00 HE
|
Laidlaw Venture Partners
NEW YORK, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the appointment of Anthony Zook and Gary...
PD Theranostics, Inc., a Laidlaw Venture Partners Portfolio Company, Executes Term Sheet With Massachusetts General Hospital
30 sept. 2021 10h37 HE
|
Laidlaw Venture Partners
NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced that its portfolio company, PD...
Algorithm Sciences, a Laidlaw Venture Partners Portfolio Company, Announces Key Management Appointments
15 sept. 2021 10h17 HE
|
Laidlaw Venture Partners
NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced key management appointments for its...
Laidlaw Venture Partners Portfolio Company Algorithm Sciences, Inc. Closes $5.0 Million Series B Financing Round
20 avr. 2021 08h15 HE
|
Laidlaw Venture Partners
NEW YORK, April 20, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the successful closing of a $5.0 million...
UPDATE – Laidlaw Venture Partners Portfolio Company AerWave Medical, Inc. Closes $4 Million Series A Financing Round
24 févr. 2021 13h33 HE
|
Laidlaw Venture Partners
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the successful closing of a $4 million...
Laidlaw Venture Partners Portfolio Company AerWave Medical, Inc. Closes $4 Million Series A Financing Round
24 févr. 2021 11h31 HE
|
Laidlaw Venture Partners
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the successful closing of a $4 million...
Laidlaw Venture Partners Portfolio Company Voltron Therapeutics Enters into Strategic Development Agreement With Translational Drug Development (TD2), a Precision Oncology Contract Research Organization (CRO)
23 nov. 2020 08h00 HE
|
Laidlaw Venture Partners
NEW YORK, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced a strategic development agreement with...
Laidlaw Venture Partners Continues Strategic Growth with the Addition of Zachary Shriver, Ph.D. and George Steinfels, Ph.D., MBA as Strategic Advisors for Key Operational Activities
27 oct. 2020 08h30 HE
|
Laidlaw Venture Partners
NEW YORK, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the addition of Zachary Shriver, Ph.D. and...
Laidlaw Venture Partners Continues Strategic Growth with Addition of Paul Korner, MD, MBA and Tony N. Hodges MD FCCP FACP, to its Investment and Operations Committee
20 oct. 2020 08h30 HE
|
Laidlaw Venture Partners
NEW YORK, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the addition of addition of Paul Korner, MD,...
Laidlaw Venture Partners Continues Strategic Growth with Addition of Mr. Anthony Zook to its Investment and Operations Committee
21 sept. 2020 08h30 HE
|
Laidlaw Venture Partners
NEW YORK, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the addition of Mr. Anthony (‘Tony’) Zook...